ArticleViruses2026

Affinity Selection of MS2 VLPs as SARS-CoV-2 Vaccine Candidates Targeting Nucleocapsid Protein.

Julianne Peabody et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.